For: | Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, van der Woude CJ. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease. World J Gastroenterol 2012; 18(47): 6967-6973 [PMID: 23322995 DOI: 10.3748/wjg.v18.i47.6967] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i47/6967.htm |
Number | Citing Articles |
1 |
Yasmin Schmid, Alexander Navarini, Zita-Rose Manjaly Thomas, Bettina Pfleiderer, Stephan Krähenbühl, Simon M Mueller. Sex differences in the pharmacology of itch therapies—a narrative review. Current Opinion in Pharmacology 2019; 46: 122 doi: 10.1016/j.coph.2019.05.008
|
2 |
André Farkouh, Christoph Baumgärtel, Roman Gottardi, Margit Hemetsberger, Martin Czejka, Alexandra Kautzky-Willer. Sex-Related Differences in Drugs with Anti-Inflammatory Properties. Journal of Clinical Medicine 2021; 10(7): 1441 doi: 10.3390/jcm10071441
|
3 |
Ross M. Maltz, Pedro Marte-Ortiz, Madeline G. McClinchie, Miranda E. Hilt, Michael T. Bailey. T Cell-Induced Colitis Is Exacerbated by Prolonged Stress: A Comparison in Male and Female Mice. Biomedicines 2024; 12(1): 214 doi: 10.3390/biomedicines12010214
|
4 |
Irina Blumenstein, Elena Sonnenberg. Sex- and gender-related differences in inflammatory bowel diseases. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1199687
|
5 |
Christine M. Madla, Francesca K.H. Gavins, Hamid A. Merchant, Mine Orlu, Sudaxshina Murdan, Abdul W. Basit. Let’s talk about sex: Differences in drug therapy in males and females. Advanced Drug Delivery Reviews 2021; 175: 113804 doi: 10.1016/j.addr.2021.05.014
|
6 |
Bruno Laganà, Angelo Zullo, Maria Lia Scribano, Maria Sole Chimenti, Alberto Migliore, Andrea Picchianti Diamanti, Roberto Lorenzetti, Palma Scolieri, Lorenzo Ridola, Elena Ortona, Marina Pierdominici, Vincenzo Bruzzese. Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00047
|
7 |
Mitchell R. K. L. Lie, Joany E. Kreijne, C. Janneke van der Woude. Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases 2017; 23(1): 75 doi: 10.1097/MIB.0000000000000981
|
8 |
Elena Sonnenberg, Alica Kubesch-Grün. Gender-Medizin bei chronisch entzündlicher Darmerkrankung. Die Gastroenterologie 2023; 18(6): 455 doi: 10.1007/s11377-023-00738-8
|
9 |
Kwi Suk Kim, Young Hee Choi, Aree Moon, Sang Geon Kim. Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting. Journal of Clinical Medicine 2020; 9(2): 461 doi: 10.3390/jcm9020461
|
10 |
Luis Fernández-Salazar, Fernando Muñoz, Jesús Barrio, Concepción Muñoz, Ramón Pajares, Montserrat Rivero, Vanessa Prieto, Jesús Legido, Abdel Bouhmidi, Maite Herranz, Nereida Fernández, Ramón Sánchez-Ocaña, Diana Joao, Fernando Santos. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study). Scandinavian Journal of Gastroenterology 2016; 51(2): 186 doi: 10.3109/00365521.2015.1070900
|
11 |
Bálint Tél, Bence Stubnya, Noémi Gede, Péter Varjú, Zoltán Kiss, Katalin Márta, Péter Jenő Hegyi, András Garami, Eszter Hegyi, Zsolt Szakács, Péter Hegyi, Gábor Veres. Inflammatory Bowel Diseases Elevate the Risk of Developing Acute Pancreatitis. Pancreas 2020; 49(9): 1174 doi: 10.1097/MPA.0000000000001650
|
12 |
Rafael Mineiro, Cecília Santos, Isabel Gonçalves, Manuel Lemos, José Eduardo B. Cavaco, Telma Quintela. Regulation of ABC transporters by sex steroids may explain differences in drug resistance between sexes. Journal of Physiology and Biochemistry 2023; 79(3): 467 doi: 10.1007/s13105-023-00957-1
|
13 |
|
14 |
Andrea Cignarella, Elisabetta Vegeto, Chiara Bolego, Luigia Trabace, Lucia Conti, Elena Ortona. Sex-oriented perspectives in immunopharmacology. Pharmacological Research 2023; 197: 106956 doi: 10.1016/j.phrs.2023.106956
|
15 |
Dana A. Salem, Rawan El-Ijla, Razan R. AbuMusameh, Khaled A. Zakout, Alaa Y. Abu Halima, Mohammed T. Abudiab, Yahya M. Banat, Basel F. Alqeeq, Mohammed Al-Tawil, Khaled Matar. Sex-related differences in profiles and clinical outcomes of Inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03514-2
|
16 |
Johannes P.D. Schultheiss, Eelco C. Brand, Evert Lamers, Willemijn C.M. van den Berg, Fiona D.M. van Schaik, Bas Oldenburg, Herma H. Fidder. Earlier discontinuation of TNF‐α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effects. Alimentary Pharmacology & Therapeutics 2019; 50(4): 386 doi: 10.1111/apt.15380
|
17 |
Janka Bábíčková, Ľubomíra Tóthová, Eva Lengyelová, Anastázie Bartoňová, Július Hodosy, Roman Gardlík, Peter Celec. Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens. Inflammation 2015; 38(5): 1996 doi: 10.1007/s10753-015-0180-7
|
18 |
Victor K. Tso, Beate C. Sydora, Rae R. Foshaug, Thomas A. Churchill, Jason Doyle, Carolyn M. Slupsky, Richard N. Fedorak, Benoit Foligne. Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease. PLoS ONE 2013; 8(7): e67654 doi: 10.1371/journal.pone.0067654
|
19 |
Pablo Garrido-Gil, Ana I Rodriguez-Perez, Lucia Lage, Jose L Labandeira-Garcia, Rozalyn M Anderson. Estrogen Deficiency and Colonic Function: Surgical Menopause and Sex Differences in Angiotensin and Dopamine Receptor Interaction. The Journals of Gerontology: Series A 2021; 76(9): 1533 doi: 10.1093/gerona/glaa244
|
20 |
Jasmijn Z. Jagt, Koen W. Holleman, Marc A. Benninga, Johan E. Van Limbergen, Nanne K. H. de Boer, Tim G. J. de Meij. Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2024; 78(1): 57 doi: 10.1002/jpn3.12041
|
21 |
I. Blumenstein, B. Siegmund, E. Sonnenberg. Geschlechtsspezifische Unterschiede bei chronisch-entzündlichen Darmerkrankungen. Der Gastroenterologe 2019; 14(2): 102 doi: 10.1007/s11377-019-0323-8
|
22 |
Mitchell R. K. L. Lie, Emma Paulides, C. Janneke van der Woude. Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events. International Journal of Colorectal Disease 2020; 35(8): 1489 doi: 10.1007/s00384-020-03663-2
|
23 |
Carole L. Galligan, Eleanor N. Fish. Sex and Gender Differences in Infection and Treatments for Infectious Diseases. 2015; : 1 doi: 10.1007/978-3-319-16438-0_1
|
24 |
Yue Yu, Jun Chen, Dingcheng Li, Liwei Wang, Wei Wang, Hongfang Liu. Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events. Scientific Reports 2016; 6(1) doi: 10.1038/srep24955
|
25 |
Patricia Louis, Brian Mercer, Aiko M. Cirone, Christina Brust, Zachary J. Lee, Nwadiuto Esiobu, Zhongwei Li, Jianning Wei, C. Kathleen Dorey, Yoshimi Shibata, Changlong Nan, George S. Deepe. Dietary Chitin Particles Called Mimetic Fungi Ameliorate Colitis in Toll-Like Receptor 2/CD14- and Sex-Dependent Manners. Infection and Immunity 2019; 87(5) doi: 10.1128/IAI.00006-19
|
26 |
Helen R. Gosselt, Jette A. van Lint, Leanne J. Kosse, Phyllis I. Spuls, Harald E. Vonkeman, Sander W. Tas, Frank Hoentjen, Michael T. Nurmohamed, Bart J.F. van den Bemt, Martijn B.A. van Doorn, Naomi T. Jessurun. Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases. Expert Opinion on Drug Safety 2023; 22(6): 501 doi: 10.1080/14740338.2023.2181340
|